ABBOTT PARK, Ill., Oct. 5, 2026 /PRNewswire/ — Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) approval for updates to the CardioMEMS HF System that enable new patient-facing capabilities through the CardioGuide HF App.
Wristband device from Encora Therapeutics started as a project in 2.009, MIT’s iconic product-design class.
MARLBOROUGH, Mass., Oct. 1, 2026 /PRNewswire/ — BTL Industries, a global leader in medical and wellness technologies, today announced expanded FDA clearances for EXOMIND®, its noninvasive brain stimulation platform.
Medtronic plans to study the device in patients with peripheral artery disease below the knee, a historically difficult condition to treat.
Edwards Lifesciences earned FDA approval for its Autus size-adjustable heart valve, a surgical pulmonary heart valve for pediatric patients with congenital heart disease, the company announced today.
Agency assigns zalunfiban (DisaggproTM) a PDUFA target action date of June 18, 2027
The panel is designed to identify 13 common bacterial and viral respiratory pathogens from one nasopharyngeal swab.
Intuitive (NASDAQ: ISRG) continues to get back to its roots, claiming a European approval for its da Vinci 5 system in minimally invasive cardiac procedures.
Mobile platform combines smartphone technology, a proprietary light-occluding headset, and AI-assisted software to capture and analyze nystagmus without complex equipment.
DALLAS, Sept. 28, 2026 /PRNewswire/ — Insera Therapeutics, Inc., a medical device company focused on advancing cyclical aspiration for mechanical thrombectomy, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CLEAR™ Aspiration System.